Nipecotic Acid CAS 498-95-3 Hale Hana Maʻemaʻe Kiʻekiʻe
Mea Manufacturer lako me High maemae a me Stable Quality, Commercial Production
Inoa Kimia | ʻAka Nipecotic |
Nā huaʻōlelo like | DL-Nipecotic Acid;3-Piperidinecarboxylic Acid;H-DL-Nip-OH |
Helu CAS | 498-95-3 |
Helu CAT | RF-PI284 |
Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona |
ʻĀpana Molekala | C6H11NO2 |
Kaumaha Molecular | 129.16 |
Hiki i ka wai | Hiki i ka wai |
Kūlana Hoʻouna | Hoʻouna ʻia ma lalo o ka wela ambient |
Brand | ʻO Ruifu Chemical |
'ikamu | Nā kikoʻī |
Ka nana aku | Keokeo a Melemele Crystalline pauda |
Decompose Mahana | ≥261.0 ℃ |
ʻIkepili | IR, NMR |
Nalo ma ka maloo | ≤1.0% |
Koena ma ka Ignition | ≤1.0% |
Hana ʻIke / ʻIke | ≥98.0% (TLC) |
Kūlana hoʻāʻo | ʻOihana Kūlana;Pākē Pharmacopoeia (CP) |
Hoʻohana | Nā Kūwaena Lapaʻau |
Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.
ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana nui a me ka mea hoʻolako o Nipecotic Acid (CAS: 498-95-3) me ke kūlana kiʻekiʻe, hoʻohana nui ʻia i ka synthesis organik, synthesis o nā intermediates pharmaceutical a me Active Pharmaceutical Ingredient (API) synthesis.ʻO ka ʻakika Nipecotic (CAS: 498-95-3) he mea hiki ke hoʻopaʻa i ka lawe ʻana o ka γ-aminobutyric acid (GABA) i nā ʻāpana lolo ʻiole.Hoʻohana ʻia nā lipophilic derivatives o ka waikawa nipecotic e like me nā lāʻau lapaʻau no ka mālama ʻana i ka epilepsy.
Palapala noi
Ua hoʻohana ʻia ka waikawa Nipecotic i ka hoʻoholo ʻana i ka lāʻau antiepileptic vigabatrin a me nā neurotransmitters amino acid i loko o ka lolo ʻiole extracellular fluid e ka capillary;electrophoresis me ka laser-induced fluorescence detection;Reactant no ka esterification concurrent a me N-acteylation o nā waikawa amino me nā orthoesters
Reactant no ka synthesis o:
Nā lāʻau anticonvulsant:HCV NS5B polymerase inhibitors;ʻO nā mea hoʻopaneʻe Cathepsin S;ʻO nā mea kūʻē P2Y12 bioavailable waha no ka pale ʻana i ka platelet aggregation;ʻO ka modulator allosteric maikaʻi o ka metabotropic glutamate receptor 4